Skip to content

Renasant RNST Granted (in shares)

Granted (in shares) at other companies

CHE
ChemedCHE
$110.38K+38.8%
The Hanover Insurance Group logo
The Hanover Insurance GroupTHG
148.1K+5.5%
John Wiley & Sons, Inc. logo
John Wiley & Sons, Inc.WLYB
0
Genpact logo
GenpactG
0
Ondas, Inc.
 logo
Ondas, Inc. ONDS
7.4M+45.6%
TRV
Trevi Therapeutics, Inc.TRVI
3.2M+27.2%

Other financials

Income statement

See full
Revenue$273.8M+60.5%
Net income$88.2M+113%
EPS (diluted)$0.94+44.6%

Balance sheet

See full
Cash & equivalents$1.2B+11.5%
Total debt$806.2M+48.9%
Total equity$3.9B+41.8%
Total assets$27.1B+48.4%

Cash flow

See full
Operating cash flow$100.1M+99.7%
CapEx$6.3M+31.3%
Free cash flow$93.7M+107%

Valuation

See full
Market cap$3.94B+55.1%

Profitability

See full
Net margin20.9%-6.4pp
FCF margin32.7%-18.2pp

Returns & leverage

See full
Return on equity6.9%-0.9pp
Debt / equity0.2×0.0×

Where this comes from

Reported directly by Renasant in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross.

The official record: Renasant’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Renasant's granted (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Renasant's granted (in shares)?
Renasant (RNST) reported granted (in shares) of 0 in Q1 2026.
What does granted (in shares) mean?
The total number of stock option shares granted to employees and directors during the reporting period. This metric provides insight into the company's equity-based incentive strategy and potential future dilution.